Chemical activators of Olr1607 include a range of compounds that trigger specific cellular pathways leading to the activation of the protein. Forskolin, for instance, raises intracellular cyclic AMP (cAMP) levels by activating adenylate cyclase. The elevation of cAMP activates protein kinase A (PKA), which then phosphorylates Olr1607, leading to its activation. Similarly, PMA (phorbol 12-myristate 13-acetate) serves as an activator of protein kinase C (PKC), which is another kinase capable of phosphorylating Olr1607. This phosphorylation event is a vital step toward the functional activation of Olr1607.
Ionomycin, by increasing cytosolic calcium concentrations, activates calcium-dependent kinases that target Olr1607 for phosphorylation. Thapsigargin contributes to this increase in intracellular calcium by inhibiting the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) pump, resulting in the release of calcium from the endoplasmic reticulum. The elevated calcium levels then activate kinases that phosphorylate and activate Olr1607. Okadaic acid and Calyculin A act by inhibiting protein phosphatases 1 and 2A, maintaining Olr1607 in a phosphorylated and active state by preventing its dephosphorylation. Anisomycin acts through the MAPK/ERK pathway, which includes a cascade of kinases, ultimately leading to the phosphorylation of Olr1607. DiC8, a diacylglycerol analog, specifically activates PKC, which phosphorylates Olr1607. Similarly, Bisindolylmaleimide I indirectly leads to the phosphorylation of Olr1607 by activating compensatory kinases in response to the inhibition of conventional PKC isoforms. H-89, while known as a PKA inhibitor, can lead to the compensatory activation of other kinases that phosphorylate Olr1607. Dibutyryl-cAMP, a stable cAMP analog, directly activates PKA, which then phosphorylates Olr1607. Lastly, A23187, a calcium ionophore, increases intracellular calcium to activate kinases that phosphorylate and activate Olr1607, completing the array of chemical activators that facilitate the functional activation of this protein through phosphorylation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates PKC, which is known to phosphorylate Olr1607, resulting in its activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, which activates calcium-dependent kinases that phosphorylate and activate Olr1607. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the SERCA pump, increasing cytosolic calcium levels, which can activate kinases that phosphorylate Olr1607. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid inhibits protein phosphatases 1 and 2A, preventing dephosphorylation and maintaining Olr1607 in an active state. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates the MAPK/ERK pathway, which includes kinases that can phosphorylate and activate Olr1607. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A inhibits protein phosphatases, leading to increased phosphorylation and activation of Olr1607. | ||||||
1,2-Dioctanoyl-sn-glycerol | 60514-48-9 | sc-202397 sc-202397A | 10 mg 50 mg | $47.00 $254.00 | 2 | |
DiC8 is an analog of diacylglycerol that activates PKC, which can phosphorylate and activate Olr1607. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I indirectly activates compensatory pathways that can lead to the phosphorylation and activation of Olr1607. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP, a cAMP analog, directly activates PKA which in turn can phosphorylate and activate Olr1607. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187, a calcium ionophore, increases intracellular calcium, activating kinases that phosphorylate and activate Olr1607. | ||||||